AnaptysBio's Big Bet: Decoding the ANB033 Play in the High-Stakes World of Rheumatoid Arthritis
$55 Million Reasons Why Your Specialty Pharmacy Experience is About to Get a Whole Lot Better: House Rx Steps Up
Cabaletta Bio's Q3 Unveils a Story of Progress and Promise in Autoimmune Therapies
A New Frontier: Pharma Titans Unite to Rewrite the Rules of Autoimmune Treatment
The Biologic Revolution: Unpacking the Promise and Price of Tomorrow's Cures
Sana Biotech Skyrockets: Eric Jackson's Bold Endorsement Fuels 50% Surge
The Mystery of Premature Greying: Could a Simple Deficiency Be the Culprit?
Unlocking the Immune System's Guardians: A Nobel-Winning Breakthrough in Self-Tolerance
Jyong Biotech's 'Cellular Communication Platform' Shines, Clinching Innovation Gold at 2025 Taipei Biotech Awards
Unlocking the Future of Health: How AI and Immunology Are Revolutionizing the Fight Against Cancer and Diabetes
Unmasking the Cellular Alarm: Scientists Pinpoint Receptors Triggering Viral 'Panic Response'
LB Pharma Targets $300 Million Valuation as It Gears Up for Landmark US IPO to Advance Autoimmune Therapies
Revolutionizing Disease Research: A Breakthrough Antibody Testing Platform Emerges
Harbour BioMed Welcomes Dr. Yajie Li as New Chief Medical Officer
Groundbreaking Study Dispels Fears: Antibiotics Unlikely to Trigger Most Autoimmune Diseases